홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 6-chloro-1-(cyclobutylmethyl)-3-methylpyrimidine-2,4(1H,3H)-dione

HRID 896041
인쇄

반응식

HRID 896041 반응식
ClCC1N[C:7](=O)[NH:6][C:5](=[O:10])C=1.[N:11]1[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=1P(C1C=CC=CC=1)C1C=CC=CC=1.[CH:30]1([CH2:34][OH:35])CC[CH2:31]1.[ClH:36]>C1COCC1.O1CCOCC1.O1CCOCC1>[Cl:36][C:31]1[N:11]([CH2:16][CH:15]2[CH2:12][CH2:13][CH2:14]2)[C:5](=[O:10])[N:6]([CH3:7])[C:34](=[O:35])[CH:30]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 313Hydrochloric AcidHCID 732736-(Chloromethyl)-2,4(1H,3H)-pyrimidinedioneHCID 78130CyclobutylcarbinolHCID 6218932-Pyridyldiphenylphosphine

생성물 1

HCID 223496026-chloro-1-(cyclobutylmethyl)-3-methylpyrimidine-2,4(1H,3H)-dione

시약·촉매·용매 2

HCID 31275
1,4-Dioxane
용매
HCID 22018518Dioxane tetrahydrofuran용매

실험 절차

To a cooled (0° C.) slurry of 6-chloromethyluracil (2.0 g, 12 mmol) in THF/dioxan (1:1, 16 ml) is added 2-pyridyldiphenylphosphine (3.60 g, 13.7 mmol) and cyclobutanemethanol (1.3 ml, 13.8 mmol), followed by di-t-butylazodicarboxylate (3.15 g, 13.7 mmol). The reaction is stirred overnight at ambient temperature, treated with 4M HCl in dioxan (15 ml) and evaporated. The residue is taken up in dichloromethane, washed with 3.5M HCl, dried over magnesium sulfate and evaporated. The crude product is purified by flash chromatography (100:1 dichloromethane-methanol elution) to afford 6-chloro-1cyclobutylmethyl-3-methyl-1H-pyrimidine-2,4-dione, 1H NMR (400 MHz, CDCl3) δ1.70-2.0 (m 6H), 2.60 (m 1H), 3.20 (s 3H), 4.00 (d J 7 2H), 5.78 (s 1H), which is dissolved in n-butanol (50 ml). Veratrylamine (4 ml, 26.5 mmol) is added and the reaction heated to reflux for 16 hours. The solvent is evaporated and the residue taken into dichloromethane, washed with 1M aqueous HCl, dried over magnesium sulfate and evaporated. The crude product is purified by flash chromatography (50:1 dichloromethane-methanol elution) to afford 1-cyclobutylmethyl-6-(3,4-dimethoxy-benzylamino)-3-methyl-1H-pyrimidine-2,4-dione, 1H NMR (400 MHz, CDCl3) d 1.60-1.80 (m 4H), 1.80-2.00 (m 2H), 2.50 (m 1H), 3.21 (s 3H), 3.80 (s 6H), 3.85 (d J 7 2H), 4.11 (d J 5 1H), 4.25 (m 1H), 4.84 (s 1H), 6.74 (s 1H), 6.80 (s 2H), which is dissolved in formic acid (50 ml) and Pd black (0.26 g) added. The reaction is heated at 40° C. for 21 hours, filtered through Celite, evaporated and purified by preparative HPLC to afford 6-amino-1-cyclobutylmethyl-3-methyl-1H-pyrimidine-2,4-dione, M+209, which is converted using the general procedure for Intermediate 1 into 5,6-diamino-1-cyclobutylmethyl-3-methyl-1H-pyrimidine-2,4-dione, HPLC retention time 0.17 mins (30-95% acetonitrile water gradient in 4 minutes).

후처리

  1. customevaporated
  2. washwashed with 3.5M HCl
  3. dry with materialdried over magnesium sulfate
  4. customevaporated
  5. customThe crude product is purified by flash chromatography (100:1 dichloromethane-methanol elution)

출처 및 근거

ORD 기록
ord-52cafbb6056846f4afea87175547cfc9
출처 데이터셋
uspto-grants-2005_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06919337B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트